What is Fuch’s endothelial dystrophy?
Fuch’s endothelial dystrophy is an inherited condition that affects the endothelium, the delicate innermost layer of the cornea. It occurs when the endothelial cells gradually deteriorate over time. Once lost, these endothelial cells do not grow back, leading to the clouding of the cornea, swelling and impaired vision.
In the early stages of the disease, patients experience increased glare and sensitivity to light. As the condition progresses, vision may become blurred in the morning, then sharpen throughout the day. As the condition worsens further, vision may appear blurry throughout the day.
Fuch’s corneal dystrophy affects both eyes and is slightly more common among women than men. It usually starts to develop at around 30 to 40 years of age with no apparent cause.
How do you treat Fuch’s endothelial dystrophy?
Our standard method to treat Fuch’s endothelial dystrophy is endothelial cell transplantation. This is where we take the cells and implant them into the eye. We use two techniques, the descemet’s stripping endothelial keratoplasty (DSEK) or descemet’s membrane endothelial keratoplasty (DMEK).
If the vision becomes severely impaired, a corneal transplant may be required.